Rejected
at 7:04 p.m. Oct, 31, 2023 ]
by
Alex
Author:
jpk429
Type of change:
Updated content
Rationale for change
Clarification on receptor selectivity
Rejection reason
sitting for over a month, another suggestion resolves this partially
Current
Suggested
Extra
Extra
Extra
Extra
Text
Terazosin is a(n) {{c1::selective α1}} receptor antagonist used to treat benign prostatic hyperplasia (BPH) in patients with {{c2::hypertension}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy


Watch Alpha Drugs


Watch Alpha Drugs
Sketchy 2




Watch Hypertension Management








Watch Hypertension Management




Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review -osin Drugs


Review -osin Drugs
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Male Pathology : Benign Prostatic Hyperplasia
Watch associated Bootcamp video - Autonomic System : Alpha Adrenergic Antagonists
Watch associated Bootcamp video - Autonomic System : Alpha Adrenergic Antagonists
Additional Resources
Empty field
One by one
Empty field
